AI takes on aortic aneurysm detection: could it beat human error?

NCT ID NCT07438327

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence software called Aorta AIM that automatically measures the size of the aorta from CT scans. The aorta can enlarge over time, leading to serious health problems, and accurate measurement is key for monitoring. Researchers will compare the AI's measurements to those made by expert radiologists using existing CT scans from 250 adults in Brazil and the U.S. No extra scans or procedures are needed, so there are no risks to participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Aorta AIM software (artificial intelligence diagnostic tool)
What this could lead to
If successful, this AI could help doctors detect and monitor aortic aneurysms more quickly and consistently, potentially leading to earlier treatment decisions.
What could go wrong
This is an early-stage study comparing AI to human experts, not a treatment trial. The AI may not work as well in all patients or hospital settings, and it won't directly improve health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC ANEURYSM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Israelita Albert Einstein

    NOT_YET_RECRUITING

    São Paulo, São Paulo, 05652-900, Brazil

  • Innovation Health Services

    RECRUITING

    Norfolk, Virginia, 23510, United States

    Contact Email: •••••@•••••

  • University of North Carolina at Chapel Hill

    NOT_YET_RECRUITING

    Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.